3 Things to Know if Chloroquine Wins the COVID-19 Treatment Race
The coronavirus pandemic has so far resulted in the shutdown of economies around the globe and driven stocks into a bear market. Biotech and pharmaceutical companies are racing to develop treatments and prevention for COVID-19, the illness caused by the new coronavirus. And at the same time, a simple malaria drug known as chloroquine and a small study out of a Marseille, France research center are making headlines -- and creating controversy.
Image source: Getty Images.
Here are three things to know if chloroquine wins the treatment race.
Source Fool.com